Inozyme Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.92
|
|
Average Rating
|
4.29
|
|
# Strong Buys
|
3
|
|
# Buys
|
3
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.43
|
-0.38
|
0.05
|
11.63%
|
|
2022-06-30
|
-0.48
|
-0.38
|
0.10
|
20.83%
|
|
2022-03-31
|
-0.82
|
-0.71
|
0.11
|
13.41%
|
|
2021-12-31
|
-0.68
|
-0.79
|
-0.11
|
-16.18%
|
|
2021-09-30
|
-0.61
|
-0.60
|
0.01
|
1.64%
|
|
2021-06-30
|
-0.57
|
-0.53
|
0.04
|
7.02%
|
|
2021-03-31
|
-0.54
|
-0.47
|
0.07
|
12.96%
|
|
2020-12-31
|
-0.55
|
-1.01
|
-0.46
|
-83.64%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.47
|
|
2021-12-31
|
-2.39
|
|
2020-12-31
|
-10.99
|